Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>A recent study found that in patients without diabetes but with insulin resistance along with a history of ischemic stroke or TIA, pioglitazone reduced the risk of stroke or myocardial infarction compared to placebo.</p>

A Secondary Prevention Against Cardiovascular Events?